Literature DB >> 1559233

Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv).

F Arguello1, R W Furlanetto, R B Baggs, B T Graves, S E Harwell, H J Cohen, C N Frantz.   

Abstract

Mice carrying mutations at the Sl (steel) and W (dominant white spotting) loci develop abnormalities on 3 migratory embryonic stem cell populations: hematopoietic stem cells, neural crest-derived melanocytes, and primordial germ cells. Transplantation experiments have indicated that the Sl locus affects the microenvironment where stem cells migrate, proliferate, and differentiate, while the W locus affects the migratory cells themselves. The Sl locus encodes for a multipotent growth factor known as stem cell factor. The W locus encodes the c-kit protein tyrosine kinase receptor whose ligand is the stem cell factor. We have investigated the incidence and organ distribution of experimental metastases after systemic intra-arterial injection of B16-G3.26 melanoma cells into mutant Sl/Sld and W/Wv mice. Both mutant mouse strains had a markedly lower incidence of ovarian metastases when compared with their congenic +/+ mice. In contrast to the rare colonization of the ovaries, Sl/Sld and W/Wv mice developed metastases in the myocardium, kidney, and stomach--anatomic sites that were infrequently or never affected in their congenic nonmutant mice. The only organs in which the average number of metastatic colonies differed between Sl/Sld and W/Wv mice were the bone marrow and kidneys. The average number of colonized bones per mouse in the Sl/Sld group was 5.0 +/- 3.1 (SD), compared with 12.7 +/- 5.3 in the W/Wv group. The average number of metastatic nodules in the kidneys of Sl/Sld mice was 24.6 +/- 9, while W/Wv mice had 15.5 +/- 2.5. Mutant mice with multiple metastatic nodules in the kidneys, heart, and stomach were also found to have forestomach papillomas, an enlarged duodenum, kidney abnormalities, and small body size. The results of this study provide useful information on potential mechanisms of interaction of metastatic cells with their target organs, and suggest that there are additional organ defects associated with the mutations in the Sl and W loci. They also document the importance of mutant mice in metastasis research.

Entities:  

Mesh:

Year:  1992        PMID: 1559233

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

Authors:  Michael O Ports; Ray B Nagle; Gerald D Pond; Anne E Cress
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

2.  Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles.

Authors:  Kate Fritton; Pei-Gen Ren; Emmanuel Gibon; Allison J Rao; Ting Ma; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2012-08-14       Impact factor: 3.845

3.  Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.

Authors:  Serk In Park; Sun Jin Kim; Laurie K McCauley; Gary E Gallick
Journal:  Curr Protoc Pharmacol       Date:  2010-12

4.  TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells.

Authors:  Alfiya Safina; Paula Sotomayor; Michelle Limoge; Carl Morrison; Andrei V Bakin
Journal:  Mol Cancer Res       Date:  2011-06-23       Impact factor: 5.852

5.  Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

Authors:  Fumitaka Takeshita; Yoshiko Minakuchi; Shunji Nagahara; Kimi Honma; Hideo Sasaki; Kotaro Hirai; Takumi Teratani; Nachi Namatame; Yusuke Yamamoto; Koji Hanai; Takashi Kato; Akihiko Sano; Takahiro Ochiya
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-09       Impact factor: 11.205

6.  Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction.

Authors:  Dae Gyu Kim; Jin Young Lee; Nam Hoon Kwon; Pengfei Fang; Qian Zhang; Jing Wang; Nicolas L Young; Min Guo; Hye Young Cho; Ameeq Ul Mushtaq; Young Ho Jeon; Jin Woo Choi; Jung Min Han; Ho Woong Kang; Jae Eun Joo; Youn Hur; Wonyoung Kang; Heekyoung Yang; Do-Hyun Nam; Mi-Sook Lee; Jung Weon Lee; Eun-Sook Kim; Aree Moon; Kibom Kim; Doyeun Kim; Eun Joo Kang; Youngji Moon; Kyung Hee Rhee; Byung Woo Han; Jee Sun Yang; Gyoonhee Han; Won Suk Yang; Cheolju Lee; Ming-Wei Wang; Sunghoon Kim
Journal:  Nat Chem Biol       Date:  2013-11-10       Impact factor: 15.040

7.  A role for leukemia inhibitory factor in melanoma-induced bone metastasis.

Authors:  Shigeaki Maruta; Soichi Takiguchi; Miho Ueyama; Yasufumi Kataoka; Yoshinao Oda; Masazumi Tsuneyoshi; Haruo Iguchi
Journal:  Clin Exp Metastasis       Date:  2008-10-25       Impact factor: 5.150

8.  The effects of Hsp90 expression alteration on spinal metastases of breast carcinoma.

Authors:  Wangjun Yan; Jianru Xiao; Tielong Liu; Wending Huang; Xinghai Yang; Zhipeng Wu; Quan Huang; Ming Qian
Journal:  Tumour Biol       Date:  2013-03-01

9.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.

Authors:  Xin Lu; Qiongqing Wang; Guohong Hu; Catherine Van Poznak; Martin Fleisher; Michael Reiss; Joan Massagué; Yibin Kang
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

Review 10.  Mechanisms involved in the metastasis of cancer to bone.

Authors:  F W Orr; P Kostenuik; O H Sanchez-Sweatman; G Singh
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.